DEXKETOPROFEN
Disc Herniation
Yonsei UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
7 Active assets in the Disc Herniation cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Midodrine Yonsei University | N/A | D |
NEPENTHE Yonsei University | N/A | D |
METAMIZOLE Yonsei University | N/A | D |
NORADRENALINE TARTRATE IMPURITY C Yonsei University | N/A | D |
Plavix Yonsei University | N/A | D |
Acetylsalicylic Acid Yonsei University | N/A | D |
METARAMINOL Yonsei University | N/A | D |
Same molecule, other indications
DEXKETOPROFEN is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →